title: Psychophysiological research in psychiatry and neuropsychopharmacology. II. The investigation of antihypoxidotic/nootropic drugs (tenilsetam and co-dergocrine-mesylate) in elderlies with the Viennese Psychophysiological Test-System (VPTS).
abstract: In a double-blind placebo-controlled study, the effects of tenilsetam, a novel antihypoxidotic/nootropic agent, on spontaneous and event-related activity of the central and autonomous nervous system were studied in 15 elderly subjects of both sexes aged 58-77 years by means of the Viennese Psychophysiological Test-System (VPTS). The VPTS includes a special selection and combination of experimental situations, physiological measurements, behavioral measurements and data analysis. At weekly intervals, the subjects received randomized single oral doses of placebo, 150 mg, 300 mg and 900 mg tenilsetam (TEN) and 5 mg co-dergocrine-mesylate (CDM) as reference drug. Psychophysiological testings were carried out before and 2 h after drug administration. Evaluation of the spontaneous EEG-activity demonstrated no significant drug effects as compared to placebo. In contrast, TEN showed a dose-dependent augmentation of the N1-P2 and N2-P300 amplitudes of the event-related potentials (ERPs) in specific experimental conditions. In reference to placebo, the increase of N2-P300 amplitude after the highest dosage of TEN, as well as after CDM, amounted to approximately 5 microV, which confirms the hypothesis that nootropic drugs may influence the P300 amplitude in the sense of an improved availability of cognitive processing resources. There was no effect on ERP latencies, on mean amplitudes of contingent negative variation and of post-imperative negative variation, on autonomous nervous system, on psychological measurements, nor on reaction time. However, specific improvements were observed in psychomotor measures, such as synchronization accuracy and rhythmicity. These findings highlight the importance of using EEG and ERP measures in different experimental situations in conjunction with behavioral, psychological and autonomous nervous system measures to study nootropic drug effects.
authors.affiliation: Department of Psychiatry, School of Medicine, University of Vienna, Austria.
authors.forename: B
authors.initials: B
authors.lastname: Saletu
authors.forename: H V
authors.initials: HV
authors.lastname: Semlitsch
authors.forename: P
authors.initials: P
authors.lastname: Anderer
authors.forename: F
authors.initials: F
authors.lastname: Resch
authors.forename: O
authors.initials: O
authors.lastname: Presslich
authors.forename: P
authors.initials: P
authors.lastname: Schuster
mesh_terms: D000368:Aged; D001767:Blinking / Q000187:drug effects; D004088:Dihydroergotoxine / Q000494:pharmacology*; D004569:Electroencephalography; D005260:Female; D006801:Humans; D000860:Hypoxia / Q000188:drug therapy* / Q000523:psychology; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000494:pharmacology*; D011597:Psychomotor Performance / Q000187:drug effects; D011603:Psychophysiology; D011619:Psychotropic Drugs / Q000494:pharmacology*; D013876:Thiophenes / Q000494:pharmacology*
chemical_list: D010879:Piperazines; D011619:Psychotropic Drugs; D013876:Thiophenes; D004088:Dihydroergotoxine; C059511:tenilsetam